Enteric Microbiota and Small Intestinal Bacterial Overgrowth

Sleisenger and Fordtran’s Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, Expert Consult Premium Edition - Enhanced Online Features and Print

Volumn , Issue , 2010, Pages 1769-1778

  O’Mahony, Seamus ^a,b   Shanahan, Fergus ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b University College Cork and INFANT Centre   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85124852983     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6189-2.00102-5     Document Type: Chapter

References (189)

1. Artis D Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut Nat Rev Immunol 8 2008 411-420(Ref 28.)
2. Backhed F., Ding H., Wang T., et al. The gut microbiota as an environmental factor that regulates fat storage Proc Natl Acad Sci U S A 101 2004 15718-15723(Ref 32.)
3. Bratten J., Spanier J., Jones MP Lactulose hydrogen breath testing does not discriminate patients with irritable bowel syndrome from healthy controls Am J Gastroenterol 103 2008 958-963(Ref 122.)
4. Castiglione F., Rispo A., Di Girolamo E., et al. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn’s disease Aliment Pharmacol Ther 18 2003 1107(Ref 163.)
5. Di Sefano M., Miceli E., Missanelli M., et al. Absorbable vs non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome Aliment Pharmacol Ther 21 2005 985(Ref 165.)
6. Marchesi J., Shanahan F The normal intestinal microbiota Curr Opin Infectious Dis 20 2007 508-513(Ref 8.)
7. O’Hara AM., Shanahan F The gut flora as a forgotten organ EMBO Rep 7 2006 688-693(Ref 2.)
8. Lauritano EC., Gabrielli M., Scarpellini E., et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy Am J Gastroenterol 103 2008 2031-2035(Ref 166.)
9. Parlesak A., Klein B., Schecher K., et al. Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalised older adults J Am Geriatr Soc 51 2003 768-773(Ref 47.)
10. Pimentel M., Park S., Mirocha J., et al. The effect of a non-absorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: A randomized trial Ann Intern Med 145 2006 557-563(Ref 125.)
11. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., et al. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis Cell 118 2004 229-241(Ref 21.)
12. Riordan SM., McIver CJ., Wakefield D., et al. Small intestinal mucosal immunity and morphometry in luminal growth of indigenous gut flora Am J Gastroenterol 96 2001 494-500(Ref 113.)
13. Romagnuolo J., Schiller D., Bailey RJ Using breath tests wisely in a gastroenterology practice: An evidence-based review of indications and pitfalls in interpretation Am J Gastroenterol 97 2002 2113-2126(Ref 49.)
14. Scarpellini E., Gabrielli M., Lauritano CE., et al. High dose rifaximin for the treatment of small intestinal bacterial overgrowth Aliment Pharmacol Ther 25 2007 781-786(Ref 164.)
15. Sharara AI., Aoun E., Abdul-Baki H., et al. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence Am J Gastroenterol 101 2006 326-333(Ref 126.)
16. Turnbaugh PJ., Ley RE., Hamady M., et al. The human microbiome project Nature 449 2007 804-810(Ref 4.)
17. Vanner S The lactulose breath test for diagnosing SIBO in IBS patients: Another nail in the coffin Am J Gastroenterol 103 2008 964-965(Ref 120.)
18. Vanner S The small intestinal bacterial overgrowth/irritable bowel syndrome hypothesis: Implications for treatment Gut 57 2008 1315-1321(Ref 45.)
19. Wigg AJ., Roberts-Thomson IC., Dymock RB The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis Gut 48 2001 206-211(Ref 130.)
20. Zoetendal EG., Akkermans ADL., Akkermans-van Vilet WM., et al. The host genotype affects the bacterial community in the human gastrointestinal tract Microb Ecol Health Dis 13 2001 129-134.
21. O’Hara AM., Shanahan F The gut flora as a forgotten organ EMBO Rep 7 2006 688-693.
22. Sonnenburg JL., Angenent LT., Gordon JI Getting a grip on things: How do communities of bacterial symbionts become established in our intestine? Nat Immunol 5 2004 569-573.
23. Turnbaugh PJ., Ley RE., Hamady M., et al. The human microbiome project Nature 449 2007 804-810.
24. Gordon JI., Hooper LV., McNevin SM., et al. Epithelial cell growth and differentiation III. Promoting diversity in the intestine: Conversations between the microflora, epithelium, and diffuse GALT Am J Physiol Gastrointest Liver Physiol 273 1997 G565-G570.
25. Xu J., Gordon JI Honor thy symbionts Proc Natl Acad Sci U S A 100 2003 10452-10459.
26. Zoetendal EG., Von Wright A., Vilpponen-Salmela T., et al. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from the feces Appl Environ Microbiol 68 2002 3401-3407.
27. Marchesi J., Shanahan F The normal intestinal microbiota Curr Opin Infectious Dis 20 2007 508-513.
28. Vaughan EE., Schut F., Heilig HG., et al. A molecular view of the intestinal ecosystem Curr Issues Intest Microbiol 1 2000 1-12.
29. Tzeneva VA., Heilig HG., van Vliet WA., et al. 16SrRNA targeted DGGE fingerprinting of microbial communities Methods Mol Biol 410 2008 335-349.
30. Collins K., O’Mahony J The “unculturables.” In: Hart AL., Stagg AJ., Graffner H., et al. Gut ecology 2002 Martin Dunitz London 25-33.
31. Dalwadi H., Wei B., Braun J Defining new pathogens and non-culturable infectious agents associated with inflammatory bowel disease Curr Opin Gastroenterol 16 2000 56-59.
32. Cohavy O., Bruckner D., Gordon LK., et al. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope Infect Immun 68 2000 1542-1548.
33. Wei B., Dalwadi H., Gordon LK., et al. Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody Infect Immun 69 2001 6044-6054.
34. Dalwadi H., Wei B., Kronenberg M., et al. The Crohn’s disease-associated bacterial protein I2 is a novel enteric T cell superantigen Immunity 15 2001 149-158.
35. Sutton CL., Kim J., Yamane A., et al. Identification of a novel bacterial sequence associated with Crohn’s disease Gastroenterology 119 2000 23-31.
36. Lodes MJ., Cong Y., Elson CO., et al. Bacterial flagellin is a dominant antigen in Crohn disease J Clin Invest 113 2004 1296-1306.
37. Midtvedt T Microbial functional activities In: Hanson LA., Yolken RH Intestinal microflora. Nestle Nutrition Workshop Series No. 42 1999 Lippincott-Raven Philadelphia 79.
38. Hooper LV., Wong MH., Thelin A., et al. Molecular analysis of commensal host-microbial relationships in the intestine Science 291 2001 881-884.
39. Hooper LV., Midvedt T., Gordon JI How host-microbial interactions shape the nutrient environment of the mammalian intestine Annu Rev Nutr 22 2002 283-307.
40. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., et al. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis Cell 118 2004 229-241.
41. Madara J Building an intestine-architectural contributions of commensal bacteria N Engl J Med 351 2004 1685-1686.
42. Shanahan F Nutrient tasting and signaling mechanisms in the gut: V. Mechanisms of immunologic sensation of intestinal contents Am J Physiol Gastrointest Liver Physiol 278 2000 G191-G196.
43. Shanahan F Pathophysiologic basis and prospects for probiotic therapy in inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol 288 2005 G417-G421.
44. Rescigno M., Urbano M., Valzasina B., et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria Nat Immunol 2 2001 361-367.
45. Macpherson AJ., Uhr T Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria Science 303 2004 1662-1665.
46. Huang Q., Liu D., Majewski P., et al. The plasticity of dendritic cell responses to pathogens and their components Science 294 2001 870-875.
47. Artis D Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut Nat Rev Immunol 8 2008 411-420.
48. Neish AS., Gewirtz AT., Zeng H., et al. Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination Science 289 2000 1560-1563.
49. Kelly D., Campbell JI., King TP., et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA Nat Immunol 5 2004 104-112.
50. Rafter J Probiotics and colon cancer Best Pract Res Clin Gastroenterol 17 2003 849-859.
51. Backhed F., Ding H., Wang T., et al. The gut microbiota as an environmental factor that regulates fat storage Proc Natl Acad Sci U S A 101 2004 15718-15723.
52. Levitt MD Volume and composition of human intestinal gas determined by means of an intestinal washout technic N Engl J Med 284 1971 1394-1398.
53. Levine AS., Bond JH., Prentiss RA., et al. Metabolism of carbon monoxide by the colonic flora of humans Gastroenterology 83 1982 633-637.
54. Levitt MD., Engel RR Intestinal gas Adv Intern Med 20 1975 151-165.
55. Levitt MD Intestinal gas production-recent advances in flatology N Engl J Med 302 1980 1474-1475.
56. Levitt MD Methane production in the gut N Engl J Med 291 1974 528-529.
57. Moore JG., Jessop LD., Osborne DN Gas-chromatographic and mass-spectrometric analysis of the odor of human feces Gastroenterology 93 1987 1321-1329.
58. Suarez FL., Springfield J., Levitt MD Identification of gases responsible for the odour of human flatus and evaluation of a device purported to reduce this odour Gut 43 1998 100.
59. Barker WH., Hummel LE Macrocytic anemia in association with intestinal strictures and anastomoses Bull Johns Hopkins Hosp 46 1939 215.
60. Batt RM., McLean L., Riley JE Response of the jejunal mucosa of dogs with aerobic and anaerobic overgrowth to antibiotic therapy Gut 29 1988 473-482.
61. Wirts CW., Goldstein F Studies of the mechanism of postgastrectomy steatorrhea Ann Intern Med 58 1963 25-36.
62. Kahn IJ., Jeffries GH., Sleisenger MH Malabsorption in intestinal scleroderma: Correction by antibiotics N Engl J Med 274 1966 1339-1344.
63. Roberts SH., James O., Jarvis EH Bacterial overgrowth without “blind loop”: A cause for malnutrition in the elderly Lancet 10 1977 1193-1195.
64. Vanner S The small intestinal bacterial overgrowth/irritable bowel syndrome hypothesis: Implications for treatment Gut 57 2008 1315-1321.
65. Lewis SJ., Potts LF., Malhotra R., Mountford R Small bowel bacterial overgrowth in subjects living in residential care homes Age Ageing 28 1999 181-185.
66. Parlesak A., Klein B., Schecher K., et al. Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalised older adults J Am Geriatr Soc 51 2003 768-773.
67. Lipski PS., Kelly PJ., James OFW Bacterial contamination of the small bowel in elderly people: Is it necessarily pathological? Age Ageing 21 1992 5-12.
68. Romagnuolo J., Schiller D., Bailey RJ Using breath tests wisely in a gastroenterology practice: An evidence-based review of indications and pitfalls in interpretation Am J Gastroenterol 97 2002 1113-1126.
69. Bouhnik Y., Alain S., Attar A., et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome Am J Gastroenterol 94 1999 1327-1331.
70. Goldstein F., Wirts CW., Kowlessar OD Diabetic diarrhea and steatorrhea: Microbiologic and clinical observations Ann Intern Med 72 1970 215.
71. Pearson AJ., Brezechwa-Ajdukiewicz A., McCarthy CF Intestinal pseudo-obstruction with bacterial overgrowth in the small intestine Am J Dig Dis 14 1969 200.
72. Griffin WO Jr., Richardson JD., Medley ES Prevention of small bowel contamination by ileocecal valve South Med J 64 1971 1056.
73. Atwater JS., Butt HR., Priestly JT Gastrojejunocolic fistulae with special reference to associated nutritional deficiencies and certain surgical aspects Ann Surg 117 1943 414.
74. Browning GG., Buchan KA., Mackay C The effect of vagotomy and drainage on the small bowel flora Gut 15 1974 139.
75. Ruddell WSJ., Losowsky MS Severe diarrhoea due to small intestinal colonization during cimetidine treatment BMJ 281 1980 273.
76. Fried M., Siegrist H., Frei R., et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole Gut 35 1994 23.
77. Thorens J., Froehlich F., Schwizer W., et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: A prospective randomised double blind study Gut 39 1996 54.
78. Pereira SP., Gainsborough N., Dowling RH Drug-induced hypochlorhydria causes high duodenal bacterial counts in the elderly Aliment Pharmacol Ther 12 1998 99.
79. McEvoy A., Dutton J., James OF Bacterial contamination of the small intestine is an important cause of occult malabsorption in the elderly Br Med J (Clin Res Ed) 287 1983 789.
80. Mitsui T., Shimaoka K., Goto Y., et al. Small bowel bacterial overgrowth is not seen in healthy adults but is in disabled older adults Hepatogastroenterology 53 2006 82.
81. Shindo K., Machida M., Miyakawa K., et al. A syndrome of cirrhosis, achlorhydria, small intestinal bacterial overgrowth, and fat malabsorption Am J Gastroenterol 88 1993 2084.
82. Morencos FC., de las Heras Castano G., Martin Ramos L., et al. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis Dig Dis Sci 40 1995 1252.
83. Chang CS., Chen GH., Lien HC., et al. Small intestinal dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis Hepatology 28 1998 1187.
84. Bauer TM., Steinbruckner B., Brinkmann FE., et al. Small intestinal bacterial overgrowth in patients with cirrhosis: Prevalence and relation with spontaneous bacterial peritonitis Am J Gastroenterol 96 2001 2962.
85. 4 breath tests Scand J Gastroenterol 33 1998 867.
86. Gunnarsdottir SA., Sadik R., Shev S., et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension Am J Gastroenterol 98 2003 1362.
87. Madrid AM., Hurtado C., Venegas M., et al. Long-term treatment with cisapride and antibiotics in liver cirrhosis: Effect on small intestinal motility, bacterial overgrowth and liver function Am J Gastroenterol 96 2001 1251.
88. Madrid AM., Brahm J., Buckel E., et al. Orthotopic liver transplantation improves small bowel motility disorders in cirrhotic patients Am J Gastroenterol 92 1997 1044.
89. Bauer TM., Schawacha H., Steinbruckner B., et al. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia Am J Gastroenterol 97 2002 2364.
90. Lorenzo-Zuniga V., Bartoli R., Planas R Oral bile acids reduce bacterial overgrowth, bacterial translocation and endotoxemia in cirrhotic rats Hepatology 37 2003 551.
91. Kay SA., Lim SG., Taylor M., et al. Small bowel bacterial overgrowth in systemic sclerosis: Detection using direct and indirect methods and treatment outcome Br J Rheumatol 34 1995 265.
92. Soudah HC., Hasler WL., Owyang C Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma N Engl J Med 325 1991 1461.
93. Virally-Monod M., Tielmans D., Kevorkian JP., et al. Chronic diarrhoea and diabetes mellitus: Prevalence of small intestinal bacterial overgrowth Diabetes Metab 24 1998 530.
94. Cuoco L., Montalto M., Jorizzo RA., et al. Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics Hepatogastroenterology 49 2002 1582.
95. Tursi A., Brandimarte G., Giorgetti G High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal Am J Gastroenterol 98 2003 839.
96. Castiglione F., Del Vecchio Blanco G., Rispo A., et al. Orocaecal transit time and bacterial overgrowth in patients with Crohn’s disease J Clin Gastroenterol 31 2000 63.
97. Mishkin D., Boston FM., Blank D., et al. The glucose breath-test: A diagnostic test for small bowel strictures in Crohn’s disease Dig Dis Sci 47 2002 489.
98. Lembeke B., Kraus B., Lankisch PG Small intestinal function in chronic relapsing pancreatitis Hepatogastroenterology 32 1985 149.
99. Rubinstein E., Mark Z., Haspel J., et al. Antibacterial activity of the pancreatic fluid Gastroenterology 88 1985 927.
100. Henriksson AE., Blomquist L., Nord CE., et al. Small intestinal bacterial overgrowth in patients with rheumatoid arthritis Ann Rheum Dis 52 1993 503.
101. Husebye E., Skar V., Hoverstad T., et al. Abnormal intestinal motor patterns explain enteric colonization with gram-negative bacilli in late radiation enteropathy Gastroenterology 109 1995 1078.
102. Strid H., Simren M., Stotzer PO., et al. Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth Digestion 67 2003 129.
103. Fridge JL., Conrad C., Gerson L., et al. Risk factors for small bowel bacterial overgrowth in cystic fibrosis J. Pediatr Gastroenterol Nutr 44 2007 212.
104. De Lisle RC., Roach EA., Norkina O Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation J Paediatr Gastroenterol Nutr 42 2006 46.
105. Weinstock LB., Klutke CG., Lin HC Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms Dig Dis Sci 53 2007 1246.
106. Parodi A., Paolino S., Greco A., et al. Small intestinal bacterial overgrowth in rosacea: Clinical effectiveness of its eradication Clin Gastroenterol Hepatol 6 2008 759.
107. Sabate JM., Jouet P., Harnois F., et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: A contributor to severe hepatic steatosis Obes Surg 18 2008 371.
108. Pimentel M., Wallace D., Hallegua D., et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing Ann Rheum Dis 63 2004 450.
109. Resmini E., Parodi A., Savarino V., et al. Evidence of prolonged orocecal transit time and small bowel bacterial overgrowth in acromegalic patients J Clin Endocrinol Metab 92 2007 2119.
110. Faber K Perniciöse Anämie bei Dunndarmstricturen Berl Klin Wochenschr 34 1897 643.
111. King CE., Toskes PP Small intestinal bacterial overgrowth Gastroenterology 76 1979 1035.
112. 12 malabsorption in intestinal bacterial overgrowth Gastroenterology 62 1972 255.
113. Welkos SL., Toskes PP., Baer H Importance of anaerobic bacteria in the cobalamin malabsorption of the experimental rat blind loop syndrome Gastroenterology 80 1981 313.
114. 12 analogues in patients with small bowel bacterial overgrowth Ann Intern Med 87 1977 546.
115. Larvol L., Eugène C., Anciaux ML., Quevauvilliers J [Polyneuritis complicating chronic bacterial colonization of the small intestine in jejunal diverticulosis] Gastroenterol Clin Biol 12 6-7 1988 585-586.
116. Tabaqchali S., Pallis C Reversible nicotinamide deficiency encephalopathy in a patient with jejunal diverticulosis Gut 11 1970 1024.
117. Hoffbrand AV., Tabaqchali S., Moilin DL High serum folate levels in intestinal blind loop syndrome Lancet 1 1966 1339.
118. Camilo E., Zimmerman J., Mason JB., et al. Folate synthesized by bacteria in the human upper small intestine is assimilated by the host Gastroenterology 110 1996 991.
119. Cameron DG., Watson GM., Witts LJ The experimental production of macrocytic anemia by operations of the intestinal tract Blood 4 1949 803.
120. King CE., Toskes PP The experimental rat blind loop preparation: A model for small-intestine bacterial overgrowth in man In: Pfeiffer CJ Animal models for intestinal disease 1985 CRC Press Boca Raton, Fla 217.
121. Tabaqchali S., Hatzioanuou J., Booth CC Bile salt deconjugation and steatorrhoea in patients with the stagnant loop syndrome Lancet 2 1968 12.
122. Kim YS., Spritz N., Blum M., et al. The role of altered bile acid metabolism in the steatorrhea of experimental blind-loop syndrome J Clin Invest 45 1966 956.
123. Schonsby H Osteomalacia in the stagnant loop syndrome Acta Med Scand Suppl 603 1977 39.
124. Brin MF., Fetell MR., Green PHA., et al. Blind loop syndrome, vitamin E malabsorption and spinocerebellar degeneration Neurology 35 1985 338.
125. Riepe SP., Goldstein J., Alpers DH Effect of secreted Bacteroides proteases on human intestinal brush border hydrolases J Clin Invest 66 1980 314.
126. Sherman P., Wesley A., Forstner G Sequential disaccharidase loss in rat intestinal blind loops: Impact of malnutrition Am J Physiol 248 1985 G626.
127. Giannella RA., Rout WR., Toskes PP Jejunal brush border injury and impaired sugar and amino acid uptake in the blind loop syndrome Gastroenterology 67 1974 95.
128. Jonas A., Krishnan C., Forstner G Pathogenesis of mucosal injury in the blind loop syndrome: Release of disaccharidases from brush border membrane extracts of bacteria obtained from intestinal blind loops in rats Gastroenterology 75 1978 791.
129. Jones EA., Craigie A., Tavill AS., et al. Protein metabolism in the intestinal stagnant loop syndrome Gut 9 1968 466.
130. Rutgeerts L., Mainguet P., Tytgat G., et al. Enterokinase in contaminated small-bowel syndrome Digestion 10 1974 249.
131. King CE., Toskes PP Protein-losing enteropathy in the human and experimental rat blind-loop syndrome Gastroenterology 80 1981 834.
132. Riordan SM., McIver CJ., Wakefield D., et al. Small intestinal mucosal immunity and morphometry in luminal growth of indigenous gut flora Am J Gastroenterol 96 2001 494-500.
133. Haboubi NY., Lee GS., Montgomery RD Duodenal mucosal morphometry of elderly patients with small intestinal bacterial overgrowth: Response to antibiotic treatment Age Ageing 20 1991 29.
134. Toskes PP., Giannella RA., Jervis HR., et al. Small intestinal mucosal injury in the experimental blind loop syndrome. Light-and electron-microscopic and histochemical studies Gastroenterology 68 1975 193.
135. Di Stefano M., Veneto G., Malservisi S., Corazza GR Small intestinal bacterial overgrowth and metabolic bone disease Dig Dis Sci 46 2001 1077.
136. Stotzer PO., Johansson C., Mellstrom D., et al. Bone mineral density in patients with small intestinal bacterial overgrowth Hepatogastroenterology 50 2003 1415.
137. Kumar A., Forsmark C., Toskes P Small bowel bacterial overgrowth, the changing face of an old disease Gastroenterology 110 1996 A340.
138. Pimentel M., Chow EJ., Lin HC Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome Am J Gastroenterol 95 2000 3503.
139. Vanner S The lactulose breath test for diagnosing SIBO in IBS patients: Another nail in the coffin Am J Gastroenterol 103 2008 964-965.
140. 14C-d-xylose and healthy controls Am J Gastroenterol 100 2005 1566.
141. Bratten J., Spanier J., Jones MP Lactulose hydrogen breath testing does not discriminate patients with irritable bowel syndrome from healthy controls Am J Gastroenterol 103 2008 958-963.
142. Posserud M., Stotzer PO., Björnsson E., et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome Gut 56 2007 802.
143. Pimentel M., Chow EJ., Lin HC Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study Am J Gastroenterol 98 2003 412.
144. Pimentel M., Park S., Mirocha J., et al. The effect of a non-absorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: A randomized trial Ann Intern Med 145 2006 557-563.
145. Sharara AI., Aoun E., Abdul-Baki H., et al. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence Am J Gastroenterol 101 2006 326-333.
146. Farrell GC Is bacterial ash the flash that ignites NASH? Gut 48 2001 148.
147. Lichtman SN., Keku J., Clark RL., et al. Biliary tract disease in rats with experimental small bowel bacterial overgrowth Hepatology 13 1991 766.
148. Lichtman SN., Keku J., Schwab JH., et al. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline Gastroenterology 100 1991 513.
149. Wigg AJ., Roberts-Thomson IC., Dymock RB The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis Gut 48 2001 206-211.
150. Simco V Fecal fat microscopy. Acceptable predictive value in screening for steatorrhea Am J Gastroenterol 75 1981 204.
151. Fine KD., Ogunji F A new method of quantitative fecal fat microscopy and its correlation with chemically measured fecal fat output Am J Clin Pathol 113 2000 528.
152. Corazza GR., Menozzi MG., Strocchi A., et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing Gastroenterology 98 1990 302.
153. Hamilton I., Worsley BW., Cobden I., et al. Simultaneous culture of saliva and jejunal aspirate in the investigation of small bowel bacterial overgrowth Gut 23 1982 847.
154. Bardhan PK., Gyr K., Beglinger C., et al. Diagnosis of bacterial overgrowth after culturing proximal small bowel aspirate obtained during routine upper gastrointestinal endoscopy Scand J Gastroenterol 27 1992 253.
155. Leon-Barua R., Gilman RH., Rodriguez C., et al. Comparison of three methods to obtain upper small bowel contents for culture Am J Gastroenterol 88 1993 925.
156. Riordan SM., McIver CJ., Duncombe VM., et al. Bacteriologic analysis of mucosal biopsy specimens for detecting small-intestinal bacterial overgrowth Scand J Gastroenterol 30 1995 681.
157. Chernov AJ., Doe WF., Gompertz D Intrajejunal volatile fatty acids in the stagnant loop syndrome Gut 13 1972 103.
158. 14C-glycocholate breath and stool bile acid determinations in patients with chronic diarrhea J Clin Gastroenterol 8 1986 258.
159. Perman JA., Modler S., Olson AC Role of pH in production of hydrogen from carbohydrates by colonic bacterial flora J Clin Invest 67 1981 643.
160. 2] measurements to quantitate carbohydrate absorption. Study of partially gastrectomized patients J Clin Invest 51 1972 1219.
161. Corazza GR., Strocchi A., Gasbarrini G Fasting breath hydrogen in celiac disease Gastroenterology 93 1987 53.
162. Thompson DG., Binfoeld P., DeBelder A., et al. Extraintestnal influences on exhaled breath hydrogen measurements during the investigation of gastrointestinal disease Gut 26 1985 1349.
163. Kerlin P., Wong L Breath hydrogen testing in bacterial overgrowth of the small intestine Gastroenterology 95 1988 982.
164. MacMahon M., Gibbons N., Mullins E., et al. Are breath hydrogen tests valid in the elderly? Gerontology 42 1996 40.
165. Bauer TM., Schwacha H., Steinbruckner B., et al. Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: Poor performance of the glucose breath hydrogen test J Hepatol 33 2000 382.
166. 14C-d-xylose breath test and the 50 gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth Digestion 61 2000 165.
167. Ghosal UC., Ghosal U., Misra A Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time Indian J Gastroenterol. 25 2006 6.
168. Rhodes JM., Middleton P., Jewell DP The lactulose hydrogen breath test as a diagnostic test for small bowel bacterial overgrowth Scand J Gastroenterol 14 1979 333.
169. Riordan SM., McIver CJ., Walker BM., et al. The lactulose breath hydrogen test and small intestinal bacterial overgrowth Am J Gastroenterol 91 1996 1795.
170. 13C-xylose breath test for the diagnosis of small bowel bacterial overgrowth in children J Pediatr Gastroenterol Nutr 25 1997 153.
171. 14C]bile acid breath test in patients with small-intestine bacterial overgrowth Dig Dis Sci 25 1980 53.
172. 14C-d-xylose breath test and jejunal cultures in 60 patients Scand J Gastroenterol 20 1985 1267.
173. 2 breath tests in patients with small intestinal bacterial overgrowth Gastroenterology 91 1986 1447.
174. 14C-d-xylose breath test for detecting bacterial overgrowth in gastrointestinal motility disorders Scand J Gastroenterol 28 1993 963.
175. Chang CS., Chen GH., Kao CH., et al. Increased accuracy of the carbon-14 d-xylose breath test in detecting small-intestinal bacterial overgrowth by correction with the gastric emptying rate Eur J Nucl Med 22 1995 1118.
176. 14C] d-xylose breath test for bacterial overgrowth Dig Dis Sci 42 1997 1587.
177. Bardhan PK., Feger A., Kogon M., et al. Urinary cholyl-PABA excretion in diagnosing small intestinal bacterial overgrowth: Evaluation of a new non-invasive method Dig Dis Sci 45 2000 474.
178. Toskes P Bacterial overgrowth of the gastrointestinal tract Adv Intern Med 38 1993 387.
179. Setchell KD., Harrison DL., Gilbert JM., et al. Serum unconjugated bile acids: Qualitative and quantitative profiles in ileal resection and bacterial overgrowth Clin Chem Acta 152 1985 297.
180. Attar A., Flourie B., Rambaud JC., et al. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: A crossover, randomised trial Gastroenterology 117 1999 794-797.
181. Di Stefano M., Malservisi S., Veneto G., et al. Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth Aliment Pharmacol Ther 14 2000 551.
182. Castiglione F., Rispo A., Di Girolamo E., et al. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn’s disease Aliment Pharmacol Ther 18 2003 1107.
183. Scarpellini E., Gabrielli M., Lauritano CE., et al. High dose rifaximin for the treatment of small intestinal bacterial overgrowth Aliment Pharmacol Ther 25 2007 781-786.
184. Di Sefano M., Miceli E., Missanelli M., et al. Absorbable vs non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome Aliment Pharmacol Ther 21 2005 985.
185. Lauritano EC., Gabrielli M., Scarpellini E., et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy Am J Gastroenterol 103 2008 2031-2035.
186. Witt K., Pedersen NT The long-acting somatostatin analogue SMS 201-995 causes malabsorption Scand J Gastroenterol 24 1989 1248.
187. Pardo A., Bartoli R., Lorenzo-Zuniga V., et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis Hepatology 31 2000 858.
188. Stotzer PO., Blomberg L., Conway PL., et al. Probiotic treatment of small intestinal bacterial overgrowth by Lactobacillus fermentum KLD Scand J Infect Dis 28 1996 615.
189. Vanderhoof JA., Young RJ., Murray N., et al. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome J Pediatr Gastroenterol Nutr 27 1998 155.